Invention Grant
- Patent Title: Glucagon-like-peptide-2 (GLP-2) analogues
-
Application No.: US15950235Application Date: 2018-04-11
-
Publication No.: US10253080B2Publication Date: 2019-04-09
- Inventor: Rasmus Just , Kirsten Lindegaard Bovbjerg , Ditte Riber , Wayne Shaun Russell
- Applicant: Zealand Pharma A/S
- Applicant Address: DK Glostrup
- Assignee: Zealand Pharma A/S
- Current Assignee: Zealand Pharma A/S
- Current Assignee Address: DK Glostrup
- Agency: Clark & Elbing LLP
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C07K14/00 ; C07K14/605 ; A61K38/26 ; A61K35/22 ; A61K35/48 ; A61K35/54 ; A61K35/64 ; A61K45/06 ; A61K35/63
Abstract:
GLP-2 analogs are disclosed which comprise one of more substitutions as compared to h[Gly2]GLP-2 and which may have the property of an altered GLP-1 activity, and their medical use. The analogs are particularly useful for the prophylaxis treatment or ameliorating of the gastro-intestinal associated side effects of diabetes.
Public/Granted literature
- US20180298077A1 GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES Public/Granted day:2018-10-18
Information query
IPC分类:
